2017   2016   2015   2014   2013   2012   2011   2010   2009   2008  

09. September 2010
Transglutaminase Newsletter September 2010 - New Catalog 2011
Document

18. July 2010
Zedira supports Gordon Conference on "Transglutaminases In Human Disease Processes"
Document

15. April 2010
CHDI Foundation names Zedira as supplier for R&D products in August 2010
Document

17. March 2010
Transglutaminase Newsletter March 2010
Document

03. February 2010
Zedira presents preclinical data at “Development of Therapies for Celiac Disease” conference in New York
Document

01. January 2010
Overview on celiac disease drug development approaches (published in the German patients magazine "DZG-Aktuell" issue 01/2010, article in German)
Document

  • News  

    • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
    • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Blog

  • Events  

    • 17th International Celiac Disease Symposium

      08.09.2017 - 10.09.2017
      New Delhi, India

    • NLSDays 2017

      12.09.2017 - 14.09.2017
      Malmö, Sweden

    • BIO-Europe

      06.11.2017 - 08.11.2017
      Berlin, Germany

    • MEDICA

      13.11.2017 - 16.11.2017
      Düsseldorf, Germany

    • Gordon Research Conference on: Transglutaminases in Human Disease Processes

      16.06.2018 - 17.06.2018
      Les Diablerets, Switzerland